Plastics are known sources of chemical
exposure and few, prominent
plastic-associated chemicals, such as bisphenol A and phthalates,
have been thoroughly studied. However, a comprehensive characterization
of the complex chemical mixtures present in plastics is missing. In
this study, we benchmark plastic consumer products, covering eight
major polymer types, according to their toxicological and chemical
signatures using in vitro bioassays and nontarget high-resolution
mass spectrometry. Most (74%) of the 34 plastic extracts contained
chemicals triggering at least one end point, including baseline toxicity
(62%), oxidative stress (41%), cytotoxicity (32%), estrogenicity (12%),
and antiandrogenicity (27%). In total, we detected 1411 features,
tentatively identified 260, including monomers, additives, and nonintentionally
added substances, and prioritized 27 chemicals. Extracts of polyvinyl
chloride (PVC) and polyurethane (PUR) induced the highest toxicity,
whereas polyethylene terephthalate (PET) and high-density polyethylene
(HDPE) caused no or low toxicity. High baseline toxicity was detected
in all “bioplastics” made of polylactic acid (PLA).
The toxicities of low-density polyethylene (LDPE), polystyrene (PS),
and polypropylene (PP) varied. Our study demonstrates that consumer
plastics contain compounds that are toxic in vitro but remain largely
unidentified. Since the risk of unknown compounds cannot be assessed,
this poses a challenge to manufacturers, public health authorities,
and researchers alike. However, we also demonstrate that products
not inducing toxicity are already on the market.